Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Treatment of acute demyelinating encephalomyelitis associated with recent rickettsial infection.
HSV-2 reactivation following influenza A H3N2 Infection in an adolescent with transverse myelitis: A case report and literature review.
Chitinase-1 in cerebrospinal fluid and white matter injury in patients with progressive multiple sclerosis.
New insights on microglial lysosomal acidification: A therapeutic target of neurodegenerative diseases.
Peripheral neuropathy in a mouse model lacking GBA1 in Schwann cells.
Central Thyroid Hormone Deprivation Disrupts Cortical Cilia and Oligodendrocyte Lineage in an Allan-Herndon-Dudley Syndrome Mouse Model.
Wernicke's encephalopathy in mixed connective tissue disease triggered by persistent vomiting: a case report and literature review.
Intestinal microbiota in neurodegeneration and ageing: Mechanisms, pathways, and therapeutic interventions.
Anakinra in Severe RSV-Associated Autoinflammatory Encephalopathy With Delayed ADEM-Like Changes.
Globoid cell leukodystrophy (Krabbe disease).
Biological and clinical stability after switching from intravenous to subcutaneous natalizumab in RRMS under standard and extended dosing.
Multiple sclerosis: 2026 update.
Alemtuzumab-Induced Graves' Disease Complicated by Pretibial Myxoedema: A Case Report.
Pooling quantitative MRI data: A multi-protocol study of healthy subcortical aging.
Adaptive oligodendrogenesis regulates blood-hypothalamus barrier permeability, hypothalamic glucose sensing and systemic glucose homeostasis in male mice.
Retinal layers prognosticate cognitive progression independent of relapse activity in multiple sclerosis.
A Systematic Literature Review of Emerging Advances in Neurological Disorders: Diagnostic Innovations, Therapeutic Strategies, and Future Directions.
Temporal changes in metabolism guide oligodendrocyte precursor cell dynamics in aging and multiple sclerosis.
Switching From Intravenous to Subcutaneous Immunoglobulin Maintenance Treatment in Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
Complement C3 inhibitory peptide AMY-101 ameliorates brain injury in a mouse model of NMOSD.
Understanding the family planning experiences and information needs of people living with multiple sclerosis: an Australian cohort study.
Corrigendum to "Diagnostic delay in patients with myelin oligodendrocyte antibody-associated disease presenting with elevated intracranial pressure" [Multiple Sclerosis and Related Disorders, Volume 112, August 2026, 107335].
Selective taste impairment in relapsing-remitting Multiple Sclerosis and Supervised Learning - driven diagnostic classification.
Associations between lifestyle factors and 2.5-year clinical outcomes differ by time since multiple sclerosis diagnosis.
CAR T cell therapy beyond cancer: current status, challenges and future prospects.

Pages